Sourcing: Drawing Upon the Experience of a Network of the World's Top Experts.

Chorus has inverted the ratio of fixed to variable spending found within many large pharma companies. Chorus does not own title to buildings, land, or equipment. Chorus is comprised of a small number of internal drug researchers and the professional external relationships they have developed over several years within the industry.
Drug development plans are created and reviewed drawing upon the experience of a network of the world's top experts in CMC, toxicology, ADME, regulatory, medical and clinical operations. With an eye on efficiently progressing to clinical proof of concept, plans are then executed using a variety of known and qualified third parties such as drug substance and drug product manufacturing firms, toxicology labs, and clinical CRUs and CROs.